NASDAQ:CCRNCross Country Healthcare Stock Price, Forecast & News

Cross Country Healthcare's stock was trading at $7.84 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, CCRN stock has decreased by 18.5% and is now trading at $6.39. View which stocks have been most impacted by Coronavirus.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cross Country Healthcare in the last year. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Cross Country Healthcare.

Cross Country Healthcare is scheduled to release its next quarterly earnings announcement on Wednesday, July 29th 2020. View our earnings forecast for Cross Country Healthcare.

Cross Country Healthcare, Inc. (NASDAQ:CCRN) announced its quarterly earnings results on Thursday, May, 7th. The business services provider reported ($0.01) EPS for the quarter, beating analysts' consensus estimates of ($0.02) by $0.01. The business services provider earned $210.06 million during the quarter, compared to the consensus estimate of $210.01 million. Cross Country Healthcare had a positive return on equity of 2.80% and a negative net margin of 6.93%. The firm's quarterly revenue was up 7.7% on a year-over-year basis. During the same period last year, the firm posted $0.02 earnings per share. View Cross Country Healthcare's earnings history.

3 brokerages have issued 1-year price targets for Cross Country Healthcare's stock. Their forecasts range from $7.00 to $9.00. On average, they expect Cross Country Healthcare's stock price to reach $8.00 in the next twelve months. This suggests a possible upside of 25.2% from the stock's current price. View analysts' price targets for Cross Country Healthcare.

News stories about CCRN stock have trended very negative recently, InfoTrie Sentiment reports. The research firm identifies positive and negative news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Cross Country Healthcare earned a media sentiment score of -3.0 on InfoTrie's scale. They also gave press coverage about the business services provider a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the company's share price in the near term. View the latest news aboutCross Country Healthcare.

Cross Country Healthcare saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 1,210,000 shares, an increase of 22.3% from the April 30th total of 989,400 shares. Based on an average trading volume of 310,600 shares, the days-to-cover ratio is presently 3.9 days. Currently, 3.5% of the company's stock are short sold. View Cross Country Healthcare's Current Options Chain.

Some companies that are related to Cross Country Healthcare include Laboratory Corp. of America (LH), Quest Diagnostics (DGX), Davita (DVA), Chemed (CHE), Amedisys (AMED), LHC Group (LHCG), AMN Healthcare Services (AMN), MEDNAX (MD), R1 RCM (RCM), CorVel (CRVL), The Providence Service (PRSC), Tivity Health (TVTY) and Interpace Diagnostics Group (IDXG). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Cross Country Healthcare investors own include NVIDIA (NVDA), Energy Transfer LP Unit (ET), Enphase Energy (ENPH), QUALCOMM (QCOM), Walt Disney (DIS), EXACT Sciences (EXAS), Ford Motor (F), Mastercard (MA), Square (SQ) and AT&T (T).

Cross Country Healthcare trades on the NASDAQ under the ticker symbol "CCRN."

Cross Country Healthcare's stock is owned by a variety of retail and institutional investors. Top institutional investors include BlackRock Inc. (15.32%), Aristotle Capital Boston LLC (6.99%), Systematic Financial Management LP (5.56%), JPMorgan Chase & Co. (4.77%), State Street Corp (3.22%) and Deutsche Bank AG (1.74%). Company insiders that own Cross Country Healthcare stock include Buffy S White, Christopher R Pizzi, Joseph Trunfio, Kevin Cronin Clark, Susan E Ball, Thomas C Dircks, W Larry Cash, William J Burns and William J Grubbs. View institutional ownership trends for Cross Country Healthcare.

CCRN stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., State Street Corp, Morgan Stanley, Morgan Stanley, Aristotle Capital Boston LLC, Deutsche Bank AG, Mackay Shields LLC, and Wells Fargo & Company MN. View insider buying and selling activity for Cross Country Healthcare.

CCRN stock was bought by a variety of institutional investors in the last quarter, including Systematic Financial Management LP, JPMorgan Chase & Co., Balyasny Asset Management LLC, Cadence Capital Management LLC, Acadian Asset Management LLC, Parametric Portfolio Associates LLC, Nuveen Asset Management LLC, and Essex Investment Management Co. LLC. Company insiders that have bought Cross Country Healthcare stock in the last two years include Buffy S White, Joseph Trunfio, Kevin Cronin Clark, Susan E Ball, Thomas C Dircks, W Larry Cash, William J Burns, and William J Grubbs. View insider buying and selling activity for Cross Country Healthcare.

Shares of CCRN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of CCRN stock can currently be purchased for approximately $6.39.

Cross Country Healthcare has a market capitalization of $239.37 million and generates $822.22 million in revenue each year. The business services provider earns $-57,710,000.00 in net income (profit) each year or $0.15 on an earnings per share basis. Cross Country Healthcare employs 1,700 workers across the globe.

The official website for Cross Country Healthcare is www.crosscountryhealthcare.com.

Cross Country Healthcare's mailing address is 5201 CONGRESS AVENUE SUITE 100B, BOCA RATON FL, 33487. The business services provider can be reached via phone at 561-998-2232 or via email at [email protected]